Can you briefly describe sapropterin's function in therapy?

What does sapropterin do in therapy?

Sapropterin, also known as BH4, is a medication used to treat phenylketonuria (PKU), a genetic disorder characterized by an inability to break down the amino acid phenylalanine (Phe). [1]

How does it work?

In people with PKU, the enzyme phenylalanine hydroxylase is deficient, resulting in excessive Phe levels in the blood. Sapropterin acts as a cofactor for this enzyme, facilitating its function and enabling individuals with PKU to metabolize Phe more efficiently. This lowers blood Phe levels, reducing the risk of neurological damage and other complications associated with the disorder. [2]

What benefits does it offer?

By stabilizing the enzyme responsible for breaking down Phe, sapropterin helps alleviate symptoms, slow disease progression, and improve the quality of life for individuals with PKU. [3]

Who benefits from sapropterin therapy?

Sapropterin is typically prescribed for patients with mild PKU variants who have residual enzyme activity. It's essential to note that sapropterin should not be used without proper medical guidance, as its efficacy can depend on individual factors, including the type and severity of PKU. [4]

References

[1] DrugPatentWatch.com (2023) - Sapropterin - Drug Patents

[2] Genetics Home Reference (2022) - Phenylalanine hydroxylase deficiency

[3] Orphanet (2022) - Sapropterin

[4] ClinicalTrials.gov - Sapropterin Study for Phenylketonuria